News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Bain Capital Life Sciences Investors, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Annexon, Inc.|
Txns:
| Bought 300,000 shares
@ $2.1324, valued at
$639.7k
|
|
| 12/10/2021 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Bought 13,458 shares
@ $9.6206, valued at
$129.5k
Bought 4,011 shares
@ $9.8442, valued at
$39.5k
Bought 21,812 shares
@ $9.5619, valued at
$208.6k
Bought 3,188 shares
@ $10.2378, valued at
$32.6k
|
|
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2021 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.|
Txns:
| Converted 6,999,998 shares
@ $0
Converted 1,334,562 shares
@ $0
Bought 100,000 shares
@ $20, valued at
$2M
Converted 35,000,001 options to buy
@ $0
Converted 6,672,819 options to buy
@ $0 |
|
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2020 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 3,333,333 shares
@ $3, valued at
$10M
|
|
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Converted 2,825,602 shares
@ $0
Converted 859,573 shares
@ $0
Bought 294,117 shares
@ $17, valued at
$5M
Converted 2,825,602 preferred shares
@ $0
Converted 859,573 preferred shares
@ $0 |
|
| 11/21/2019 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 1,750,000 shares
@ $22.03, valued at
$38.6M
|
|
| 09/19/2019 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Converted 6,078,103 shares
@ $0
Converted 1,053,204 shares
@ $0
Bought 150,000 shares
@ $18, valued at
$2.7M
Converted 6,078,103 convertible preferred
@ $0
Converted 1,053,204 convertible preferred
@ $0 |
|
| 05/31/2019 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 1,600,000 shares
@ $12.5, valued at
$20M
|
|
| 07/26/2018 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Converted 2,338,968 shares
@ $0
Bought 500,000 shares
@ $15, valued at
$7.5M
Converted 235,146 convertible preferred
@ $0 |
|
| 12/19/2017 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Sold 719,665 shares
@ $8.0179, valued at
$5.8M
Sold 102,882 shares
@ $8.636, valued at
$888.5k
Sold 300,000 shares
@ $7.5048, valued at
$2.3M
Sold 94,771 shares
@ $7.6209, valued at
$722.2k
Sold 55,229 shares
@ $7.1055, valued at
$392.4k
|
|
| 12/19/2017 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Bought 285,000 shares
@ $7, valued at
$2M
Exercised 8,454,388 shares
@ $0
Granted 190,849 shares
@ $0
Exercised 250,000 options to buy
@ $3.19, valued at
$797.5k
|
|
|
|